Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
Mattias LorentzonJaime BrancoMaria Luisa BrandiOlivier BruyèreRoland ChapurlatCyrus CooperBernard CortetAdolfo Diez-PerezSerge FerrariAndrea GasparikMarkus HerrmannNiklas Rye JorgensenJohn KanisJean-Marc KaufmanAndrea LaslopMédéa LocquetRadmila MatijevicEugene McCloskeySalvatore MinisolaRichard PiknerJean-Yves ReginsterRené RizzoliPawel SzulcMila VlaskovskaCavalier EtiennePublished in: Advances in therapy (2019)
In conclusion, the currently available evidence indicates that the principal clinical utility of BTMs is for monitoring oral bisphosphonate therapy.